Novel Drug Delivery Systems: A Rational Approach to Optimal Therapeutic Outcomes

Now day’s Recent advances in the understanding of pharmacokinetic & pharmacodynamic behaviour of drug have offer a more rational approach to the development of optimal drug delivery system. Now it's appreciable that future success in Drug delivery research will largely be result of multidisplinary efforts. If any therapeutic agent that can be the more efficacious and safe using and improved drug delivery system represent both lucrative marketing opportunities for pharmaceutical company and advancement in the treatment of diseases of mindkind. An ideally design drug delivery system delivers a specified amount of drug to target particular site at an appropriate time and rate as dictated or desired by the etiological and physiological needs of the body. Conventional Pharmaceutical Dosage forms are incapable of controlling the rate of drug delivery to target site. As a result the distribution of drug in nontarget tissue and body fluids necessitate therapeutic doses that could far exceed the amount required in target cells, the higher doses often lead to serious adverse during treatment thus, the novel drug delivery systems (NDDS) are carriers which maintain the drug concentration in therapeutic range for longer period of time and also, in addition, may deliver the content to the site of action if so desired as per requirements.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-06-23
DOI
https://doi.org/10.5281/zenodo.15718611
Primary Topic
Salmonella and Campylobacter epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Novel Drug Delivery Systems: A Rational Approach to Optimal Therapeutic Outcomes

Zenodo (CERN European Organization for Nuclear Research)
Salmonella and Campylobacter epidemiology
article

Novel Drug Delivery Systems: A Rational Approach to Optimal Therapeutic Outcomes

article en

Abstract

Now day’s Recent advances in the understanding of pharmacokinetic & pharmacodynamic behaviour of drug have offer a more rational approach to the development of optimal drug delivery system. Now it's appreciable that future success in Drug delivery research will largely be result of multidisplinary efforts. If any therapeutic agent that can be the more efficacious and safe using and improved drug delivery system represent both lucrative marketing opportunities for pharmaceutical company and advancement in the treatment of diseases of mindkind. An ideally design drug delivery system delivers a specified amount of drug to target particular site at an appropriate time and rate as dictated or desired by the etiological and physiological needs of the body. Conventional Pharmaceutical Dosage forms are incapable of controlling the rate of drug delivery to target site. As a result the distribution of drug in nontarget tissue and body fluids necessitate therapeutic doses that could far exceed the amount required in target cells, the higher doses often lead to serious adverse during treatment thus, the novel drug delivery systems (NDDS) are carriers which maintain the drug concentration in therapeutic range for longer period of time and also, in addition, may deliver the content to the site of action if so desired as per requirements.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 50%
Salmonella and Campylobacter epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Novel Drug Delivery Systems: A Rational Approach to Optimal Therapeutic Outcomes · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS